| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | We are tackling the $8B global sleep apnoea burden affecting over 67M people annually. Our flagship device offers a simpler, more comfortable alternative to CPAP and mandibular systems, with early trials showing a 73% reduction in apnoea events, exceeding FDA efficacy thresholds. With CE/TGA approvals, 5 patents, and tooling complete, we’re commencing a 30-patient clinical trial led by a world-recognised sleep medicine expert with over 150 peer-reviewed publications. |
| Category: | Health & biotech |
| URL: | https://www.birchal.com/company/bioanalytics |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | |
| Address: | SYDNEY |
| State: | New South Wales |
| Overseas Operations: | No |
| X: | |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/bioanalytics-holdings/ |
| Founders: | |
| Awards won: | |
